Skip to content

RAES PHARMACEUTICAL LOGISTICS

Active
Public limited companyfounded 2013active for 13 yearsMoerstraat 48/50, 9031 Gent, BelgiumKBO/BCE: BE 0525.781.372
Summary

RAES PHARMACEUTICAL LOGISTICS has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.4m and a net result of €813,666. Equity has been growing by about 3.3% per year since 2018. Its solvency ranks better than 55% of 6,172 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Official details

Source: KBO
Status
Active since 04-04-2013 Normal situation
Activity
Wholesale of pharmaceutical and medical goods NACE 46460and 1 other
Joint committees
140.03 Paritair Subcomité voor het wegvervoer en de logistiek voor rekening van derden
226 Paritair Comité voor de bedienden uit de internationale handel, het vervoer en de logistiek · annual accounts 2025
Establishment units
2.218.860.944 9031 Gent, since 05-04-2013
2.344.259.871 9031 Gent, since 01-01-2021
Financial year end
31 December
Peppol
Reachable since 26-11-2025

Board and ownership

Board
Shareholders
  • NEST30-06-2025 annual accounts of NEST

Financial position

91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Annual accounts 2025
Gross margin
€3.8m
▲ 45.6%
Turnover
≈ €16.0m
estimated
Profit
€813,666
▲ 246%
Equity
€1.4m
▲ 140%
Total assets
€2.8m
▲ 7.6%
Employees on 31-12-2025
47
▲ 51.6%
Net result +246%: other schema
Score breakdownlowers riskFigures for financial year 2025 (filed on 15-07-2026)Founded in 2013Profit of €813,666 (financial year 2025)Equity €1.4m (49.3% of total assets)Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 73% of small companies in wholesale trade (NACE 46)
Financial strength · tick: 2024
Strong
Solvency 74+27
equity 49.3% of total assets
Liquidity 36+17
short-term debt 41.6% · cash 4.5%
Profitability 100+20
return on assets 28.8%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (4,372 companies, NACE 46, small)
Last 24 months 12-2024: 1.9% 01-2025: 2.0%▲ +0.1 percentage points vs 12-2024 02-2025: 2.0%● unchanged vs 01-2025 03-2025: 2.3%▲ +0.3 percentage points vs 02-2025 04-2025: 2.4%▲ +0.1 percentage points vs 03-2025 05-2025: 2.4%● unchanged vs 04-2025 06-2025: 2.5%▲ +0.1 percentage points vs 05-2025highest value 07-2025: 0.5%▼ -2.0 percentage points vs 06-2025 08-2025: 0.5%● unchanged vs 07-2025 09-2025: 0.5%● unchanged vs 08-2025 10-2025: 0.5%● unchanged vs 09-2025 11-2025: 0.5%● unchanged vs 10-2025 12-2025: 0.5%● unchanged vs 11-2025 01-2026: 0.5%● unchanged vs 12-2025 02-2026: 0.5%● unchanged vs 01-2026 03-2026: 0.6%▲ +0.1 percentage points vs 02-2026 04-2026: 0.6%● unchanged vs 03-2026 05-2026: 0.6%● unchanged vs 04-2026 06-2026: 0.7%▲ +0.1 percentage points vs 05-2026 07-2026: 0.7%● unchanged vs 06-2026 08-2026: 0.2%▼ -0.5 percentage points vs 07-2026lowest value 09-2026: 0.2%● unchanged vs 08-2026lowest value 10-2026: 0.2%● unchanged vs 09-2026lowest value 11-2026: 0.2%● unchanged vs 10-2026lowest value
Credit of up to €120,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.65 (1.05 in 2024), above the usual 1.5. Short-term debt is 41.6% and cash 4.5% of total assets. However, 50.7% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, small). It does better than 58% of them on solvency, 38% on liquidity, 99% on profitability and 97% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Figures for financial year 2025 (filed on 15-07-2026)
NBB · annual accounts
lowers risk · Founded in 2013
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Profit of €813,666 (financial year 2025)
NBB · annual accounts
lowers risk · Equity €1.4m (49.3% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-07-2026, 16 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
16 days early
2024
35 days early
2023
2 days early
2022
5 days early
2021
44 days early
2020
2 days early
2019
27 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 11 days before the deadline. In the sector (NACE 46), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 15 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Result rose in 2025different schema filed ▲ 246% View
  • Higher gross margin than 95% of companies in wholesale tradesector median €354,995 · 3,311 companies €3.8m View
  • Positive: Filed on time since financial year 2020accounts within the deadline every year 6 years View

Recent changes

  1. · Gazette deed Reappointments: RAES Dirk, RAES Nele and VAN BASTELAERE Frank
  2. · Gazette deed Incorporation
All 18 events

Comparable companies

These companies have the same main activity as RAES PHARMACEUTICAL LOGISTICS: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €1.6m and €6.1m, founded between 2003 and 2018.

CompanyTotal assetsGross margin
RAES PHARMACEUTICAL LOGISTICS Gent€2.8m€3.8m
Mobilae België Sint-Martens-Latem€2.7m€2.9m
Gedeon Richter Benelux Dilbeek€2.9m€5.6m
HIPRA BENELUX Gent€5.0m€4.1m
PILEJE BENELUX Sint-Pieters-Woluwe€1.6m€2.9m
Eqwal Care Gent€6.1m€4.6m
BRUSSELS REPS PHARMA Anderlecht€3.3m€3.5m
Full comparison

Key facts about RAES PHARMACEUTICAL LOGISTICS

What is the company number of RAES PHARMACEUTICAL LOGISTICS?
The company number of RAES PHARMACEUTICAL LOGISTICS is 0525.781.372. The VAT number is the same number with BE in front: BE 0525.781.372.
Where is RAES PHARMACEUTICAL LOGISTICS based?
The registered office is at Moerstraat 48/50, 9031 Gent.Company details
What does RAES PHARMACEUTICAL LOGISTICS do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of RAES PHARMACEUTICAL LOGISTICS?
The legal form of RAES PHARMACEUTICAL LOGISTICS is Public limited company (NV).
When was RAES PHARMACEUTICAL LOGISTICS founded?
RAES PHARMACEUTICAL LOGISTICS was founded on 04-04-2013.
Is RAES PHARMACEUTICAL LOGISTICS still active?
Yes, RAES PHARMACEUTICAL LOGISTICS is an active enterprise in the KBO register.
How many employees does RAES PHARMACEUTICAL LOGISTICS have?
RAES PHARMACEUTICAL LOGISTICS had an average of 43.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does RAES PHARMACEUTICAL LOGISTICS fall under?
In its 2025 annual accounts, RAES PHARMACEUTICAL LOGISTICS states joint committees 140.03 (Paritair Subcomité voor het wegvervoer en de logistiek voor rekening van derden) and 226 (Paritair Comité voor de bedienden uit de internationale handel, het vervoer en de logistiek).
What is the turnover of RAES PHARMACEUTICAL LOGISTICS?
The turnover in financial year 2025 is ≈ €16.0m. This figure is estimated from the gross margin of €3.8m and 98 comparable companies (NACE 46). It probably lies between €9.6m and €27.0m.
Is RAES PHARMACEUTICAL LOGISTICS profitable?
In financial year 2025, RAES PHARMACEUTICAL LOGISTICS made a profit of €813,666.
Where can I find the annual accounts of RAES PHARMACEUTICAL LOGISTICS?
RAES PHARMACEUTICAL LOGISTICS filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of RAES PHARMACEUTICAL LOGISTICS due?
RAES PHARMACEUTICAL LOGISTICS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.